Millions of mild asthma patients may not need daily inhaled steroid therapy, benefiting instead from taking only when symptoms occur

New research has shown that the millions of people who use corticosteroids prescribed daily to control mild asthma do no better than those who use them only when symptoms occur. The findings suggest a potential new treatment option that could change international standards of care, reduce patients' pharmacy costs, limit long-term exposure to corticosteroids and enable flexibility in managing the condition.

Read the whole article on Science Daily

More from Science Daily